Tag Archives: Improved.

Man Utd make improved £75m Jadon Sancho transfer bid as Dortmund set out terms for move

Manchester United have submitted an improved £75million bid for Jadon Sancho of Borussia Dortmund as Ole Gunnar Solskjaer looks to land his top target ahead of the new season, according to reports. The 21-year-old has been on the club’s radar for some time and could finally make the switch to Old Trafford this summer after the Red Devils failed in their efforts to secure his services a year ago.

United pushed hard to sign Sancho last summer but were unable to meet Dortmund’s reported nine-figure asking price which ultimately poured cold water on their hopes of a deal.

The England man stayed in Germany as a result and went on to play a significant role in helping the Bundesliga heavyweights to achieve Champions League qualification and seal their fifth DFB-Pokal triumph.

Sancho chipped in with 16 goals and 20 assists in all competitions, earning a place in Gareth Southgate’s final 26-man squad for Euro 2020 in the process.

United have rekindled their interest in the Camberwell native ahead of the new campaign, with Solskjaer keen on adding a top-class winger to his ranks in order to aid a renewed Premier League title challenge.

Sancho is said to be a priority target for the 20-time champions, who acted on their desire to bring the former City starlet back to Manchester with a formal offer, according to German newspaper Ruhr Nachrichten.

JUST IN: Ramos’ positive comments on Man Utd transfer after Real Madrid exit

And it is now believed that United have returned with a second bid for the player, with personal terms said to have already been settled.

However, the offer reportedly fails to match Dortmund’s valuation of £81.6million plus bonuses, a figure that is understood to be non-negotiable.

Sancho’s current employers want the situation to be resolved by mid-July at the latest, suggesting that United could miss out on his signature once again if they fail to strike a deal at club level within the next four weeks.

It seems as though Dortmund are planning for life without the forward after reportedly identifying PSV Eindhoven teenager Noni Madueke as a potential replacement.


It remains to be seen whether United will be able to complete a move for Sancho this time around, but the Old Trafford club appear determined to follow through on their interest after years of admiring the player from afar.

Solskjaer’s side have looked two or three players short of being able to challenge City for the Premier League title in recent outings, and the addition of Sancho would see the 47-year-old benefit from the additional star quality at his disposal.

However, former Liverpool forward John Barnes recently suggested that United will struggle to return to the summit even if they manage to land the Dortmund winger this summer.

“They’ll still be inconsistent,” Barnes told Bonus Code Bets earlier this month.

“Manchester United’s problem hasn’t been their attacking play and scoring goals. They’ve got [Edinson] Cavani, [Mason] Greenwood, [Anthony] Martial, [Marcus] Rashford, [Bruno] Fernandes and [Paul] Pogba, they’re all good attackers.

“Sancho will add to that, but their problem is that they’ve not been consistent enough and they’ve conceded goals and lost matches because they’re not strong enough defensively.

“It’ll be a good signing for them – a young English player which is what you want in the squad. But I don’t think it will make them challengers.

They’ll be in the top four, but they’re not consistent enough and they haven’t got the right balance between attack and defence to compete with Manchester City or Liverpool.”

This post originally appeared on Daily Express :: Sport Feed

Vaccines and Improved Covid Tests Could Aid U.S. School Reopenings

After a school year rife with debate over the safety of returning to classrooms, experts say that the United States is edging closer to a safe return to in-person learning in the fall.

First, there is continuing good news on the vaccine front. Last month, about 17 million children ages 12 to 15 became eligible to get the Pfizer-BioNTech vaccine. And Moderna plans this month to ask the Food and Drug Administration to clear its vaccine for use in 12- to 17-year-olds.

For more than a year, parents across the United States have scrambled to adapt to online learning and keep their children focused. (And parents who balanced remote learning with work were the lucky ones. Many others lost their jobs, lacked adequate internet access or stopped work to tend to their families.)

Until vaccines are approved for children of all ages, rapid antigen testing might be the best way to limit rare outbreaks of the virus, detect them early and keep schools open consistently.

There are signs that Abbott’s BinaxNOW, a widely available antigen test, is highly sensitive in young children with symptoms of Covid-19, according to a small new study. Among children younger than 7, the test detected 100 percent of coronavirus cases, researchers write in a forthcoming paper in the journal Pediatrics.

The study, led by researchers at the Children’s Hospital of Pittsburgh, enrolled 199 children and young adults, ranging from 2 months to 20 years old. All participants had at least one symptom of Covid-19 and had been symptomatic for less than a week.

The Abbott test was somewhat less sensitive in older children, however, and generated a substantial number of false positives in children of all ages. Among children who did not have the virus, 8 to 10 percent tested positive on the antigen test, the researchers found.

“One hundred percent sensitivity in children less than seven years is excellent — outstanding,” said Dr. Alejandro Hoberman, a pediatrician at the Children’s Hospital of Pittsburgh and the senior author of the study. “The problem was the false positives.”

The findings suggest that while the test could help schools and day cares operate more safely, it might be more useful for ruling infections out than at definitively detecting them.

Experts say that more research is needed. “It is important data to have, but we need reinforcing studies that replicate what this study has done with larger numbers of children,” said Dr. Irwin Redlener, a pediatrician and founding director of the National Center for Disaster Preparedness at Columbia University.

Dr. Redlener expects that all children will be eligible to be vaccinated against Covid-19 toward the end of the year or early in 2022.

Dr. Anthony S. Fauci, President Biden’s chief medical adviser for the pandemic, said in an interview with CNN on Thursday that he was “cautiously optimistic” that children younger than 12 would be eligible for vaccinations by Thanksgiving.

Until then, experts are confident that masks, distancing, hand washing, cleaning and ventilation — along with rapid tests — can enable a return to full-time in-person classroom settings.

Mara Aspinall, an expert in biomedical diagnostics at Arizona State University, said that children had become comfortable with tests to the point of administering swabs themselves. “The perception of testing — that it was expensive, it took a long time, it was tickling your brain — none of that is true anymore,” she said. “We’ve made such progress on the technology.”

Having this kind of testing available everywhere, Dr. Redlener said, “should help reassure schools and parents that it’s safe to return to the classroom.”

Author: Lauren McCarthy and Emily Anthes
This post originally appeared on NYT > U.S. News

The Pandemic in the U.S. Has Vastly Improved. For These Families, the Worst Has Just Begun.

For families of those who are dying now, the entire issue of vaccination has created a new layer of discomfort — and a set of difficult questions no one was asking in the early months of the crisis, before vaccines.

Hollie Rivers has been devastated in the weeks since her husband, Antwone, died in Michigan. Mr. Rivers had helped raise their blended family of five children, Ms. Rivers said, and had worked his way up to the manager level at his job at a vehicle logistics company. She said he became her life partner — the “Charlie,” as she called him, to her “Angel.” At his funeral in May, she helped carry the coffin.

“I wanted to hold him until the very end, until I couldn’t hold him any longer,” Ms. Rivers, 28, said.

But after Ms. Rivers gave an interview to a Detroit-area television station and disclosed that her husband had not been vaccinated, she said she faced critical comments online. She and her husband had been initially hesitant, she said, but were considering getting the vaccine. Then Mr. Rivers, 40, got sick in early April, his wife said, before Michigan opened up vaccination to people his age.

Ms. Rivers described some online comments, including on a family GoFundMe page, as plainly hostile: “He refused the shot, how could you dare ask for money?” she recalled the tone of one message suggesting.

“Now I just feel like I want to cancel it. It’s not about money,” said Ms. Rivers, who is on short-term leave from her job installing car door panels. “I would live in a cardboard box if it meant my husband coming back to me and his kids.”

Dr. Miles, the epidemiologist who studies grief, said she had seen such dynamics play out in deaths from diseases like lung cancer or diabetes.

Author: Sarah Mervosh
This post originally appeared on NYT > U.S. News